Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters

Infection and Immunity

Volumn 65, Issue 1, 1997, Pages 171-178

  McSorley, Stephen J ^a   Xu, Damo ^a   Liew, F Y ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; SALMONELLOSIS VACCINE;

ARTICLE; DRUG EFFICACY; GENE EXPRESSION REGULATION; HOST RESISTANCE; INFECTION PREVENTION; INTERFERON PRODUCTION; LEISHMANIA DONOVANI; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; STRAIN DIFFERENCE; VACCINATION;

EID: 0031013562     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.1.171-178.1997     Document Type: Article

References (40)

1. Amann, F., J. Brosius, and M. Ptashne. 1983. Vectors bearing a hybrid trp-lac promoter useful for regulated expression of cloned genes in Escherichia coli. Gene 15:167-178.
2. + for all three chromosomally located systems of DNA restriction and modification. J. Bacteriol. 156:471-474.
3. Button, L. L., D. G. Russell, H. L. Klein, E. Medina-Acosta, R. E. Kavers, and W. R. McMaster. 1989. Genes encoding the major surface glycoprotein in Leishmania are tandemly linked at a single chromosomal locus and are constitutively transcribed. Mol. Biochem. Parasitol. 32:271-284.
4. Chabalgoity, A., C. M. A. Khan, A. A. Nash, and C. E. Hormanaeche. 1996. A Salmonella typhimurium aroA live vaccine expressing multiple copies of a peptide comprising amino acid 8-24 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection. Mol. Microbiol. 19:791-801.
5. Chatfield, S. N., I. G. Charles, A. J. Makoff, M. D. Oxer, G. Dougan, D. Pickard, D. Slater, and N. F. Fairweather. 1492. Use of the nirB promoter to direct the stable expression of hclerologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Biotechnology 10:888-892.
6. Cole, J. A. 1968. Cytochrome c552 and nitrate reduction in Escherichia coli. Biochim. Biophys. Acta 162:356-368.
7. Coulson, N. M., M. Fulop, and R. W. Titball. 1994. Bacillus anthracis protective antigen, expressed in Salmonella typhimurium SL3261, affords protection against anthrax spore challenge. Vaccine 12:1395-1401.
8. Davis, R. W., D. Botstein, and J. R. Roth. 1980. Advanced bacterial genetics. In A manual for genetic engineering. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
9. Everest, P., G. Frankel, J. Li, P. Lund, S. Chatfield, and G. Dougan. 1995. Expression of lacZ from the hrtA, nirB and groE promoters in a salmonella vaccine strain: influence of growth in mammalian cells. FEMS Microbiol. Lett. 125:97-101.
10. Gutierrez, C., and C. Devedjian. 1990. Osmotic induction of gene OsmC expression in Escherichia coli K12. J. Mol. Biol. 220:959-973.
11. Heinzel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffman, and R. M. Locksley. 1989. Reciprocal expression of interferon-gamma or interleukin-4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:59-72.
12. Hess, J., I. Gentschev, D. Milko, M. Welzel, C. H. Ladel, W. Goebel, and S. H. E. Kaufmann. 1996. Superior efficacy of secreted over somatic antigen display in vaccine induced protection against an intacellular bacterial pathogen. Proc. Natl. Acad. Sci. USA 93:1458-1463.
13. Hohmann, E. L., C. A. Oletta, W. P. Loomis, and S. I. Miller. 1995. Macrophage-inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity. Proc. Natl. Acad. Sci. USA 92:2904-2908.
14. Hone, D. M., S. Attridge, L. van der Bosch, and J. Hackett. 1988. A chromosomal integration system for stabilization of heterologous genes in Salmonella based vaccine strains. Microb. Pathog. 5:407-418.
15. Jayaraman, P. S., T. C. Peakmen, S. J. W. Busby, R. V. Quincey, and J. A. Cole. 1987. Location and sequence of the promoter of the gene for the NADH-dependent nitrate rcductase of Escherichia coli and its regulation by oxygen, the Fnr protein and nitrate. J. Mol. Biol. 196:781-788.
16. Karem, K. L., S. Chatfield, N. Kuklin, and B. T. Rouse. 1995. Differential induction of carrier antigen specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice. Infect. Immun. 63:4557-4563.
17. Kaye, P. M. 1987. Acquisition of cell mediated immunity to Leishmania I. Primary T cell activation detected by IL-2 receptor expression. Immunology 61:345-349.
18. Khan, C. M. A., B. Villarreal-Ramos, R. J. Pierce, G. Riveau, R. Demarco de Hormaeche, H. McNeill, T. Ali, S. Chatfield, A. Capron, G. Dougan, and C. E. Hormaeche. 1994. The construction, expression and immunogenicity of multiple copies of the Schistosoma mansoni peptide comprising amino acids 115-121 of the P28 glutathione S-transferase, expressed as C-terminal fusions to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella. J. Immunol. 153:5632-5642.
19. Khan, C. M. A., B. Villarreal-Ramos, R. J. Pierce, G. Riveau, R. Demarco de Hormaeche, H. McNeil, T. Ali, S. Chatfield, A. Capron, G. Dougan, and C. E. Hormaeche. 1994. The construction, expression and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella. Proc. Natl. Acad. Sci. USA 91:11261-11265.
20. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of hacteriophage T4. Nature 277:680-685.
21. Lederberg, M. M., and S. N. Cohen, Jr. 1974. Transformation of Salmonella typhimurium by plasmid deoxyribonucleic acid. J. Bacteriol. 119:1072-1075.
22. Liew, F. Y., and J. S. Dhaliwal. 1987. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunisation with killed parasites. J. Immunol. 138: 4450-4456.
23. - T cells that do not mediate cutaneous DTH. J. Immunol. 132:456-461.
24. Liew, F. Y., and C. A. O'Donnell. 1993. Immunology of leishmaniasis. Adv. Parasitol. 32:161-259.
25. Liew, F. Y., C. Parkinson, S. Millott, A. Severn, and M. J. Carrier. 1990. Tumour necrosis factor (TNFα) in leishmaniasis. 1. TNFα mediates hostprotection against cutaneous leishmaniasis. Immunology 69:570-573.
26. Maskell, D. J., K. J. Sweeney, D. O'Callaghan, C. E. Hormaeche, F. Y. Liew, and G. Dougan. 1987. Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotnxin B subunit to the murine secretory and systemic immune systems. Microb. Pathog. 2:211-221.
27. + expression-cloning vector: stable maintenance and high level expression of cloned ecnes in a salmonella vaccine strain. Bio/Technology 6:693-697.
28. Newton, S. M. C., P. E. Klebba, M. Hofnung, and A. Charbit. 1995. Studies of the anaerobically inducible promoter pnirB and the improved expression of bacterial antigens. Res. Microbiol. 146:193-202.
29. O'Callaghan, D., D. Maskell, F. Y. Liew, C. S. F. Easmon, and G. Dougan. 1988. Characterization of aromatic-dependent and purine-depcndent Salmonella typhimurium: studies on attenuation, persistence, and ability to induce protective immunity in BALB/c mice. Infect. Immun. 56:419-423.
30. Oxer, M. D., C. M. Bentley, J. G. Doyle, T. C. Peakman, I. G. Charles, and A. J. Makoff. 1991. High level heterologous expression in E. coli using the anaerobically-activatcd nirB promoter. Nucleic Acids Res. 19:2889-2892.
31. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177.
32. L promoter of coliphage lambda. Gene 15:167-178.
33. Stauber, L. A. 1958. Host resistance to the Khartoum strain of Leishmania donovani. Rice Inst. Pamph. 45:80-91.
34. Strugnell, R., G. Dougan, S. Chatfield, I. Charles, N. Fairweather, J. P. Tite, J. L. Li, J. Beesley, and M. Roberts. 1992. Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis. Infect. Immun. 60:3994-4002.
35. Strugnell, R., D. Maskell, N. Fairweather, D. Pickard, A. Cockayne, C. Penn, and G. Dougan. 1990. Stable expression of foreign antigens from the chromosome of Salmonella typhimurium vaccine strains. Gene 88:57-63.
36. Tartera, C., and E. S. Metcalf. 1993. Osmolarity and growth phase overlap in regulation of Salmonella typhi adherence to and invasion of human intestinal cells. Infect. Immun. 61:3084-3089.
37. Tijhaar, E. J., Y. Zheng-Xin, J. A. Karlas, T. F. Meyer, M. Stukart, A. D. M. E. Osterhaus, and F. R. Mooi. 1994. Construction and evaluation of an expression vector allowing the stable expression of foreign antigens in a Salmonella typhimurium vaccine strain. Vaccine 12:1004-1011.
38. Tzschaschel, B. D., G. A. Guzman, K. N. Timmis, and V. de Lorenzo. 1996. An Escherichia coli hemolysin transport system-based vector for the export of polypeptides: export of Shiga-like toxin IIeB subunit by Salmonella typhimurium aroA. Nat. Biotechnol. 14:765-769.
39. -). Immunology 85:1-7.
40. -) vaccine expressing a major leishmanial surface protein (gp63) preferentially induced Th1 cells and protective immunity against leishmaniasis. J. Immunol. 145:2281-2285.